Literature DB >> 21126202

Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility.

Orna Avlas1, Reut Fallach, Asher Shainberg, Eyal Porat, Edith Hochhauser.   

Abstract

Toll-like receptors (TLRs) have been identified as primary innate immune receptors for the recognition of pathogen-associated molecular patterns by immune cells, initiating a primary response toward invading pathogens and recruitment of the adaptive immune response. TLRs, especially Toll-like receptor 4 (TLR4), can also be stimulated by host-derived molecules and are expressed in the cardiovascular system, thus acting as a possible key link between cardiovascular diseases and the immune system. TLR4 is involved in the acute myocardial dysfunction caused by septic shock and myocardial ischemia. We used wild-type (WT) mice, TLR4-deficient (TLR4-knockout [ko]) mice, and chimeras that underwent myeloablative bone marrow transplantation to dissociate between TLR4 expression in the heart (TLR4-ko/WT) and the immunohematopoietic system (WT/TLR4-ko). Following lipopolysaccharide (LPS) challenge (septic shock model) or coronary artery ligation, myocardial ischemia (MI) model, we found WT/TLR4-ko mice challenged with LPS or MI displayed reduced cardiac function, increased myocardial levels of interleukin-1β and tumor necrosis factor-α, and upregulation of mRNA encoding TLR4 prior to myocardial leukocyte infiltration. The cardiac function of TLR4-ko or WT/TLR4-ko mice was less affected by LPS and demonstrated reduced suppression by MI compared with WT. These results suggest that TLR4 expressed in the cardiomyocytes plays a key role in this acute phenomenon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21126202     DOI: 10.1089/ars.2010.3728

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  37 in total

1.  Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression.

Authors:  Ming Gao; Xiaohui Wang; Xia Zhang; Tuanzhu Ha; He Ma; Li Liu; John H Kalbfleisch; Xiang Gao; Race L Kao; David L Williams; Chuanfu Li
Journal:  J Immunol       Date:  2015-06-05       Impact factor: 5.422

2.  Risk factors in heart disease: therapeutic interventions.

Authors:  Nilanjana Maulik; Juan A Sanchez
Journal:  Antioxid Redox Signal       Date:  2011-06-08       Impact factor: 8.401

Review 3.  Innate immunity and cardiomyocytes in ischemic heart disease.

Authors:  Li Lin; Anne A Knowlton
Journal:  Life Sci       Date:  2014-01-28       Impact factor: 5.037

Review 4.  Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?

Authors:  Thanat Chaikijurajai; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2021-02-09

5.  Crocin attenuates isoprenaline-induced myocardial fibrosis by targeting TLR4/NF-κB signaling: connecting oxidative stress, inflammation, and apoptosis.

Authors:  Weiyue Jin; Yuanyuan Zhang; Yurun Xue; Xue Han; Xuan Zhang; Zhihong Ma; Shijiang Sun; Xi Chu; Jie Cheng; Shengjiang Guan; Ziliang Li; Li Chu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-07       Impact factor: 3.000

Review 6.  Role of microRNAs in sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Inflamm Res       Date:  2017-03-03       Impact factor: 4.575

7.  Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium.

Authors:  Kevin J Ashton; Melissa E Reichelt; S Jamal Mustafa; Bunyen Teng; Catherine Ledent; Lea M D Delbridge; Polly A Hofmann; R Ray Morrison; John P Headrick
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

Review 8.  Recent advances of adapter proteins in the regulation of heart diseases.

Authors:  Li Tao; Linna Jia; Yuntian Li; Chengyun Song; Zheng Chen
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

9.  Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling.

Authors:  Bing Sun; Jing Xiao; Xiao-Bo Sun; Ying Wu
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 10.  [Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy].

Authors:  L Martin; M Derwall; C Thiemermann; T Schürholz
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.